Verified peer comparison
Mesoblast vs Hemab Therapeutics Financial Comparison
Mesoblast versus Hemab Therapeutics using 2025 financials in USD.
Direct answer
Mesoblast and Hemab Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Mesoblast email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Mesoblast Revenue
- 17,198,000 USD
- Hemab Therapeutics Revenue
- 0 USD
- Mesoblast Operating income
- -62,443,000 USD
- Hemab Therapeutics Operating income
- -70,119,000 USD